Northern Light Venture Capital
Menlo Park, Californianlvc.com
Overview
Northern Light Venture Capital is a US-China cross-border venture capital firm that invests in early- and growth-stage technology, healthcare, and consumer companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vibrant Therapeutics | Jan 2026 | Series B | Co-investor |
| Spiro Medical, Inc. | Jan 2026 | Series A | Co-investor |
| Spiro Medical | Jan 2026 | Series A | Co-investor |
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Kind Pharmaceuticals | Nov 2025 | Series C | Co-investor |
Key People
Bin Li
Operating Partner
Vivian Infan. Lee
Venture Partner
Figo Zhang
Partner
Fiona Yu
Partner
He HUANG
Partner
Lu lin
Partner
吴锋 wufeng
Partner, Director
Fabio Jaco
Investor
Zhanjie Ma
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
